NemaGen Discoveries
NemaGen Discoveries is creating therapies for mastocytosis, food allergy, asthma, urticaria, and atopic dermatitis by inhibiting carbonic anhydrase 1 (Car1) in mast cell precursors to safely impair mast cell development.
NemaGen Discoveries is creating therapies for mastocytosis, food allergy, asthma, urticaria, and atopic dermatitis by inhibiting carbonic anhydrase 1 (Car1) in mast cell precursors to safely impair mast cell development.